Psychological distress associated with the diagnostic phase for suspected breast cancer: systematic review

Montgomery, M.; McCrone, Susan

doi:10.1111/j.1365-2648.2010.05439.x

Cited by 141 publications

(140 citation statements)

References 35 publications

Supporting

Mentioning

124

Contrasting

Unclassified

Order By: Relevance

“…Additionally, women with the self-perception of having more risk about breast cancer and with a history of breast cancer in their family are also found to have higher levels of anxiety about breast cancer. It is concluded that some women with a history of breast cancer in their family or with an experience of breast cancer have negative experiences such as fear, anxiety, uncertainty and helplessness (Brain et al, 2008;Montgomery and McCrone, 2010;Tastan et al, 2011). One study dealing with young women with a history of breast cancer in their family indicates that women experience cancer anxiety before the screening and that this anxiety continues even the results of the screening are positive (Brain et al 2008).…”

Section: Discussionmentioning

confidence: 99%

Identifying Women's Knowledge about Risk Factors of Breast Cancer and Reasons for Having Mammography

Güvenç

Güvenç²,

Taştan³

et al. 2012

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

The aim of this study was to identify breast cancer risk factors and reasons for having mammography of the women who applied for mammography, as well as to determine their level of knowledge about risk factors and level of risk perception, and anxiety concerning breast cancer. This cross-sectional descriptive study was conducted from June 15, 2010 through September 10, 2010, in a university hospital in Ankara, Turkey. A questionnaire prepared by the researchers was used to collect the data. The mean age of the women was 52.1±9.98 years. Sixteen percent of the women had a family history of breast cancer. The majority of participants had mammograms (75.8%) before and had gained knowledge about breast cancer and its screening (73.7%). The leading source of information about breast cancer was physicians (46.2%). Physician recommendations, having breast-related complaints, and family history of breast cancer were important reasons to obtain mammography. The mean knowledge score about risk factors of breast cancer was 4.15±2.73 and the mean anxiety score was 1.65±1.61. It was found that some socio-demographic and obstetrical characteristics of women, their family history, and risk perceptions about breast cancer affect their knowledge and anxiety scores about breast cancer. In conclusion, the present study identified a number of factors affecting mammography participation for women. The results of this study can be helpful in promoting screening for breast cancer.

show abstract

Section: Discussionmentioning

confidence: 99%

Identifying Women's Knowledge about Risk Factors of Breast Cancer and Reasons for Having Mammography

Güvenç

Güvenç²,

Taştan³

et al. 2012

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

show abstract

“…Psychological distress, chiefly in the form of anxiety, may be experienced by women from the initial diagnostic procedures for a suspected breast cancer 36 through all stages of treatment and beyond. 37,38 In addition to psychological aspects, women may experience a range of physical problems, for example arm and breast symptoms and/or lymphoedema 39,40 and fatigue.…”

Section: Impact Of Breast Cancermentioning

confidence: 99%

The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation

Picot

Copley

Colquitt

et al. 2015

Health Technol Assess

View full text Add to dashboard Cite

BackgroundInitial treatment for early breast cancer is usually either breast-conserving surgery (BCS) or mastectomy. After BCS, whole-breast external beam radiotherapy (WB-EBRT) is the standard of care. A potential alternative to post-operative WB-EBRT is intraoperative radiation therapy delivered by the INTRABEAM®Photon Radiotherapy System (Carl Zeiss, Oberkochen, Germany) to the tissue adjacent to the resection cavity at the time of surgery.ObjectiveTo assess the clinical effectiveness and cost-effectiveness of INTRABEAM for the adjuvant treatment of early breast cancer during surgical removal of the tumour.Data sourcesElectronic bibliographic databases, including MEDLINE, EMBASE and The Cochrane Library, were searched from inception to March 2014 for English-language articles. Bibliographies of articles, systematic reviews, clinical guidelines and the manufacturer’s submission were also searched. The advisory group was contacted to identify additional evidence.MethodsSystematic reviews of clinical effectiveness, health-related quality of life and cost-effectiveness were conducted. Two reviewers independently screened titles and abstracts for eligibility. Inclusion criteria were applied to full texts of retrieved papers by one reviewer and checked by a second reviewer. Data extraction and quality assessment were undertaken by one reviewer and checked by a second reviewer, and differences in opinion were resolved through discussion at each stage. Clinical effectiveness studies were included if they were carried out in patients with early operable breast cancer. The intervention was the INTRABEAM system, which was compared with WB-EBRT, and study designs were randomised controlled trials (RCTs). Controlled clinical trials could be considered if data from available RCTs were incomplete (e.g. absence of data on outcomes of interest). A cost–utility decision-analytic model was developed to estimate the costs, benefits and cost-effectiveness of INTRABEAM compared with WB-EBRT for early operable breast cancer.ResultsOne non-inferiority RCT, TARGeted Intraoperative radioTherapy Alone (TARGIT-A), met the inclusion criteria for the review. The review found that local recurrence was slightly higher following INTRABEAM than WB-EBRT, but the difference did not exceed the 2.5% non-inferiority margin providing INTRABEAM was given at the same time as BCS. Overall survival was similar with both treatments. Statistically significant differences in complications were found for the occurrence of wound seroma requiring more than three aspirations (more frequent in the INTRABEAM group) and for a Radiation Therapy Oncology Group toxicity score of grade 3 or 4 (less frequent in the INTRABEAM group). Cost-effectiveness base-case analysis indicates that INTRABEAM is less expensive but also less effective than WB-EBRT because it is associated with lower total costs but fewer total quality-adjusted life-years gained. However, sensitivity analyses identified four model parameters that can cause a switch in the treatment option that is considered cost-effective.LimitationsThe base-case result from the model is subject to uncertainty because the disease progression parameters are largely drawn from the single available RCT. The RCT median follow-up of 2 years 5 months may be inadequate, particularly as the number of participants with local recurrence is low. The model is particularly sensitive to this parameter.Conclusions and implicationsA significant investment in INTRABEAM equipment and staff training (clinical and non-clinical) would be required to make this technology available across the NHS. Longer-term follow-up data from the TARGIT-A trial and analysis of registry data are required as results are currently based on a small number of events and economic modelling results are uncertain.Study registrationThis study is registered as PROSPERO CRD42013006720.FundingThe National Institute for Health Research Health Technology Assessment programme. Note that the economic model associated with this document is protected by intellectual property rights, which are owned by the University of Southampton. Anyone wishing to modify, adapt, translate, reverse engineer, decompile, dismantle or create derivative work based on the economic model must first seek the agreement of the property owners.

show abstract

“…Biopsy and medical investigation can be the "most anxiety-provoking stage for many patients and families" and fear is present in all patients facing surgery for cancer (Jaftha & Brainers, 1995:174-175). Undergoing biopsy causes emotional turmoil in patients (Montgomery & McCrone, 2010:2388. Patients who continue with the process of searching for a diagnosis live with uncertainty and disruption of self-identity on a daily basis (Kralik, Brown & Koch, 2001:595).…”

Section: Reaction To Cancer Diagnosismentioning

confidence: 99%

The Social Functioning of Women With Breast Cancer in the Context of the Life World: A Social Work Perspective

Wyk

Carbonatto

2016

SWORK

View full text Add to dashboard Cite

Breast cancer is the most common form of cancer in women worldwide (CANSA, 2010). The goal of this study was to explore the social functioning of women with breast cancer. A qualitative research approach was followed with a collective case study research design. In this study non-probability, purposive sampling was used to select participants. One of the themes generated was the impact of breast cancer on social functioning in the context of the life world. This theme includes changes in personality; feeling like a woman; changes in spiritual aspects; and self-image. Research showed that there were mainly positive changes experienced.

show abstract

Psychological distress associated with the diagnostic phase for suspected breast cancer: systematic review

Abstract: It is necessary to understand the impact of factors on distress so that heightened levels can be predicted and targeted by interventions initiated at the first mention of the possibility of the presence of malignancy.

Cited by 141 publications

References 35 publications

Identifying Women's Knowledge about Risk Factors of Breast Cancer and Reasons for Having Mammography

Identifying Women's Knowledge about Risk Factors of Breast Cancer and Reasons for Having Mammography

The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation

The Social Functioning of Women With Breast Cancer in the Context of the Life World: A Social Work Perspective

Contact Info

Product

Resources

About